These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16219306)

  • 1. Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation.
    Taniguchi T; Doe N; Matsuyama S; Kitamura Y; Mori H; Saito N; Tanaka C
    FEBS Lett; 2005 Oct; 579(25):5704-12. PubMed ID: 16219306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SJLB mice develop tauopathy-induced parkinsonism.
    Takenokuchi M; Kadoyama K; Chiba S; Sumida M; Matsuyama S; Saigo K; Taniguchi T
    Neurosci Lett; 2010 Apr; 473(3):182-5. PubMed ID: 20178834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.
    Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M
    Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
    Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice.
    Pennanen L; Welzl H; D'Adamo P; Nitsch RM; Götz J
    Neurobiol Dis; 2004 Apr; 15(3):500-9. PubMed ID: 15056457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairments in impulse control in mice transgenic for the human FTDP-17 tauV337M mutation are exacerbated by age.
    Lambourne SL; Humby T; Isles AR; Emson PC; Spillantini MG; Wilkinson LS
    Hum Mol Genet; 2007 Jul; 16(14):1708-19. PubMed ID: 17517691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
    Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
    Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain.
    Arendash GW; Lewis J; Leighty RE; McGowan E; Cracchiolo JR; Hutton M; Garcia MF
    Brain Res; 2004 Jun; 1012(1-2):29-41. PubMed ID: 15158158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a phosphosensor dye in proteomic analysis of human mutant tau transgenic mice.
    Takano M; Otani M; Sakai A; Kadoyama K; Matsuyama S; Matsumoto A; Takenokuchi M; Sumida M; Taniguchi T
    Neuroreport; 2009 Dec; 20(18):1648-53. PubMed ID: 19898260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
    Dawson HN; Cantillana V; Chen L; Vitek MP
    J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of mouse model exhibiting neurofibrillary changes].
    Takashima A
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1111-2. PubMed ID: 12235811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
    Sydow A; Mandelkow EM
    Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau.
    Tanemura K; Akagi T; Murayama M; Kikuchi N; Murayama O; Hashikawa T; Yoshiike Y; Park JM; Matsuda K; Nakao S; Sun X; Sato S; Yamaguchi H; Takashima A
    Neurobiol Dis; 2001 Dec; 8(6):1036-45. PubMed ID: 11741399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice.
    Pennanen L; Wolfer DP; Nitsch RM; Götz J
    Genes Brain Behav; 2006 Jul; 5(5):369-79. PubMed ID: 16879631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
    Köhler C; Bista P; Götz J; Schröder H
    Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular analysis of tau deposited in the FTDP-17 brain].
    Morishima-Kawashima M
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1107-10. PubMed ID: 12235810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.
    Lim F; Hernández F; Lucas JJ; Gómez-Ramos P; Morán MA; Avila J
    Mol Cell Neurosci; 2001 Dec; 18(6):702-14. PubMed ID: 11749044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.